Its key analytical value is retaining the position of each transcript signal, so expression can be interpreted within a cell or tissue region rather than as an isolated molecular measurement. In cancer research, this links gene activity to tumor and immune cell states, heterogeneous microenvironments, invasive regions, and treatment responses.
Labeled probes hybridize to selected target transcripts and can be read through imaging. Sequencing-based approaches instead use spatially assigned barcodes, allowing transcript identities to be connected to positions after sequencing. These alternatives preserve the central relationship between RNA identity and location while using different readout strategies.
The workflow begins by fixing tissue sections or intact specimens and then permeabilizing them before probe or barcode exposure. Within the described method, these preparation steps establish the sample state needed for molecular access while retaining the specimen’s spatial context, which is necessary for assigning signals to cells or tissue regions.
Researchers prepare a tissue section or intact specimen, fix and permeabilize it, and expose the sample to labeled probes or sequencing-based barcodes. After target recognition, imaging or sequencing reads the molecular signals and assigns them to cellular or tissue positions, producing a spatial map of transcript distribution.
It is especially useful when the biological question depends on where expression occurs. In cancer studies, spatial measurements can distinguish tumor and immune cell states across heterogeneous microenvironments, then relate those patterns to invasive regions or treatment responses. This added context supports biomarker discovery and more precise models of tumor biology.
The maps reveal how gene activity is organized across cells and tissue regions, allowing investigators to compare molecular patterns with cancer-associated organization. They can identify localized states, examine relationships between tumor and immune compartments, and connect transcript distributions with invasion or response patterns, generating evidence for biomarkers and refined tumor models.